Breast Cancer
There are a number of different types of breast cancer. The most common form of breast cancer is ductal...
Male Breast Cancer
Breast cancer may occur in men. Although it is relatively rare—less than 1% of breast cancer diagnoses in the...
Overcoming Triple-Negative Breast Cancer
After her own fight against cancer, Melanie Nix works to help other breast cancer patients and advocates in support...
Living with Metastatic Breast Cancer
Lori Marx-Rubiner views research as the key to new treatments that balance control of her cancer with a high...
Surviving Metastatic Breast Cancer; Advocating for Other Cancer Patients
Metastatic breast cancer survivor’s journey from “What did I do wrong?” to “What can I do now?” At the...
Living With Stage 4 Breast Cancer
After her breast cancer recurred and metastasized, Janet Klein participated in a clinical trial for palbociclib, which has kept...
Triumphant Thriver: Empowering Others Through Breast Cancer Advocacy
After overcoming stage 3 breast cancer, 11-year survivor Jess Whorton became a healthcare and survivorship advocate. I am an...
Tracee Guilford: Balancing Aggressive Treatment with Parenting Duties
Tracee drew strength from family and friends as she juggled cancer treatments and her children’s busy schedules. I often...
A Breast and Colon Cancer Survivor Supports Cancer Research
Suzanne got back to a rigorous exercise regime after undergoing treatment for colon cancer and then breast cancer. After...
Emily Garnett
After a fairly easy pregnancy, my husband and I welcomed our son into our lives. But I began experiencing...
Remaining Strong When Expectations Change
Roxanne Caletena recalls the day she got diagnosed and the changes she had to make to her life plan....
Less Treatment Is More for Early-stage Breast Cancer
Two studies show that breast-conserving surgery plus radiation may be a better choice than mastectomy plus reconstruction for women...
Highlights from the 2015 San Antonio Breast Cancer Symposium
Finding the latest discoveries in breast cancer care together. More than 7,000 breast cancer researchers, survivors, advocates, and others...
Diet in Adolescence Linked to Breast Cancer Risk Factor
The types of fats that girls consume during adolescence could influence their breast density, a risk factor for breast...
Assessing Type 2 Diabetes and Breast Cancer Risk
Study: Non-obese diabetic African-American women may have a higher risk of developing ER-negative breast cancer. A recent study published...
Indigenous American Ancestry May Be Associated with Aggressive Breast Cancer Subtype
A new study finds that Latina women with a higher proportion of Indigenous American ancestry may be at increased...
First Immunotherapeutic Approved for Breast Cancer
The FDA approval is for the use of atezolizumab in combination with Abraxane for the treatment of certain patients...
Identifying Breast Cancer Patients Likely to Respond to Chemotherapy
Using whole-genome sequencing, researchers have found mutational patterns that may identify breast cancer patients most likely to benefit from...
Examining Disparities in Triple-Negative Breast Cancer
The lack of androgen receptor protein may contribute to racial disparities in survival for women with this aggressive form...
First Targeted Therapeutic for BRCA-mutant Breast Cancer
The FDA has approved the molecularly targeted therapeutic olaparib for treating patients who have HER2-negative breast cancer and who...
Circulating Tumor DNA Levels After Preliminary Therapy May Better Predict Breast Cancer
ctDNA status may also inform treatment plan. Breast cancer is the most common form of non-skin cancer in the...
Targeting HER2-positive Breast Cancer
The FDA has approved a new HER2-targeted therapeutic for the treatment of certain patients with early-stage breast cancer. The...
A Breast Cancer Treatment Shows Clinical Activity in Multiple Cancer Types
A new study suggests that a HER2-targeted therapy approved for breast cancer may be effective for several other cancers....
New Combination Therapy for Early-stage Breast Cancers
Some patients with stage 2 or 3 breast cancer may now receive ribociclib with an aromatase inhibitor after surgery. ...
Targeting Triple-negative Breast Cancer
The FDA has approved a type of molecularly targeted therapeutic called an antibody-drug conjugate for the treatment of metastatic...
Florida Study Shows Breast Cancer Death Rates Decreasing Faster For Black Women Than White Women
Despite progress, the Florida study found that the breast cancer death rate for Black women remained higher than for...
HER2-targeting Therapy for HER2-ultralow Breast Cancer
The FDA has approved fam-trastuzumab deruxtecan-nxki for certain HER2-low or HER2-ultralow breast cancers. The U.S. Food and Drug Administration...
A New Targeted Treatment for HER2-positive Breast Cancer
The FDA approved a new treatment for adults with advanced breast cancer that has developed resistance to other targeted...
Inavolisib Regimen Approved for Certain Treatment-resistant Breast Cancers
The PI3K inhibitor is approved as part of combination therapy for certain patients whose breast cancer recurred on or...
Expanding Treatment Options for an Aggressive Breast Cancer
The FDA has approved a new targeted therapeutic for certain patients with HER2-positive breast cancer who were previously treated with other targeted therapies....